A case of Hallervorden-Spatz disease presenting as catatonic schizophrenia

Indian Journal of Psychiatry

Volumn 55, Issue 4, 2013, Pages 386-389

  Pawar, Yogesh ^a   Kalra, Gurvinder ^b   Sonavane, Sushma ^a   Shah, Nilesh ^a  

^a Department of Psychiatry   (India)

^b Mahatma Gandhi Mission Institute of Health Sciences   (India)

Author keywords

Catatonia; Hallervorden Spatz disease; tiger eye appearance

Indexed keywords

BACLOFEN; BROMOCRIPTINE; CLOZAPINE; CREATINE KINASE; DIAZEPAM; DOPAMINE; MAGNESIUM SULFATE; TRIHEXYPHENIDYL; VALPROIC ACID;

ADULT; AGGRESSIVENESS; ARTICLE; BODY POSTURE; CAG REPEAT; CASE REPORT; CATATONIA; CATATONIC SCHIZOPHRENIA; CERULOPLASMIN BLOOD LEVEL; CONFUSION; CREATINE KINASE BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EATING DISORDER; ELECTROCONVULSIVE THERAPY; FAHR DISEASE; FECES INCONTINENCE; FOLLOW UP; GENETIC SCREENING; GLOBUS PALLIDUS; HAND; HUMAN; HUNTINGTON CHOREA; HYDRATION; HYPOPARATHYROIDISM; LEG; MALE; MEDICAL HISTORY; MENTAL DETERIORATION; MENTAL DISEASE; MOUTH; MUSCLE RIGIDITY; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROLEPTIC INDUCED DEFICIT SYNDROME; NEUROLEPTIC INDUCED EXTRAPYRAMIDAL REACTION; NEUROLEPTIC MALIGNANT SYNDROME; OUTPATIENT DEPARTMENT; PSYCHOSIS; REFLEX DISORDER; SLEEP DISORDER; SUSPICIOUSNESS; TREMOR; WILSON DISEASE;

EID: 84890037495     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.120553     Document Type: Article

References (18)

1. Pascual GJ. Enfermedades degenerativas del sistema nervioso. In: Rodes J, Guardia J, editors. Medicina Interna. Tomo II. Barcelona: Masson; 1997.
2. Schneider SA, Hardy J, Bhatia KP. Iron accumulation in syndromes of neurodegeneration with brain iron accumulation 1 and 2: Causative or consequential? J Neurol Neurosurg Psychiatry 2009;80:589-90.
3. Neumann M, Adler S, Schluter O, Kremmer E, Benecke R, Kretzschmar HA. Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies. Acta Neuropathol 2000;100:568-74.
4. Taylor TD, Litt M, Kramer P, Pandolfo M, Angelini L, Nardocci N, et al. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet 1996;14:479-81.
5. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-9.
6. Hayflick SJ. First scientific workshop on Hallervorden-Spatz syndrome: Executive summary. Pediatr Neurol 2001;25:99-101.
7. Morphy MA, Feldman JA, Kilburn G. Hallervorden-Spatz disease in a psychiatric setting. J Clin Psychiatry 1989;50:66-8.
8. Öner Ö, Öner P, Deda G, Içaǧasioǧlu D. Psychotic disorder in a case with Hallervorder-Spatz disease. Acta Psychiatr Scand 2003;108:394-7.
9. Panas M, Spengos K, Koutsis G, Tsivgoulis G, Sfagos K, Kalfakis N, et al. Psychosis as presenting symptoms in adult onset Hallervorden-Spatz syndrome. Acta Neuropsychiatr 2007;19:122-4.
10. Sunwoo YK, Lee JS, Kim WH, Shin YB, Lee MJ, Cho IH, et al. Psychiatric disorder in two siblings with Hallervorden-Spatz disease. Psychiatry Investig 2009;6:226-9.
11. Rossi D, De Grandis E, Barzaghi C, Mascaretti M, Garavaglia B, Zanotto E, et al. Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation. Brain Dev 2012;34:536-8.
12. Chiapparini L, Savoiardo M, D'Arrigo S, Reale C, Zorzi G, Zibordi F, et al. The "eye-of-the-tiger" sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration. Neuropediatrics 2011;42:159-62.
13. Sethi KD, Adams RJ, Loring DW, el Gammal T. Hallervorden-Spatz syndrome: Clinical and magnetic resonance imaging correlations. Ann Neurol 1988;24:692-4.
14. Abbruzzese G, Cossu G, Balocco M, Marchese R, Murgia D, Melis M, et al. A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica 2011;96:1708-11.
15. Zorzi G, Zibordi F, Chiapparini L, Bertini E, Russo L, Piga A, et al. Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial. Mov Disord 2011;26:1756-9.
16. Ge M, Zhang K, Ma Y, Meng FG, Hu WH, Yang AC, et al. Bilateral subthalamic nucleus stimulation in the treatment of neurodegeneration with brain iron accumulation type 1. Stereotact Funct Neurosurg 2011;89:162-6.
17. Hickman SJ, Ward NS, Surtees RA, Stevens JM, Farmer SF. How broad is the phenotype of Hallervorden-Spatz disease? Acta Neurol Scand 2001;103:201-3.
18. Gillberg C. Clinical Child Neuropsychiatry. 1sted. Cambridge: Cambridge University Press; 2003. p. 210.